Canale-Theakston Carin 4
4 · Cidara Therapeutics, Inc. · Filed Jun 24, 2021
Insider Transaction Report
Form 4
Canale-Theakston Carin
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-23+17,500→ 17,500 totalExercise: $1.92Exp: 2031-06-22→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders.